| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Hillstream BioPharma Inc. | 10%+ Owner | Common stock | 636K | $320K | $0.50 | Jan 11, 2022 | Indirect |
| Unicycive Therapeutics, Inc. | Director | Stock Options | 201K | Sep 5, 2023 | Direct | ||
| Instil Bio, Inc. | CFO and CBO | Employee Stock Option (right to buy) | 80K | Feb 10, 2024 | Direct | ||
| Instil Bio, Inc. | CFO and CBO | Employee Stock Option (right to buy) | 45K | Sep 18, 2024 | Direct | ||
| BioXcel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 17K | Jun 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TIL | Instil Bio, Inc. | Sep 18, 2024 | 1 | $0 | 4 | Sep 23, 2024 | CFO and CBO |
| BTAI | BioXcel Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| TIL | Instil Bio, Inc. | Feb 10, 2024 | 1 | $0 | 4 | Feb 13, 2024 | CFO and CBO |
| UNCY | Unicycive Therapeutics, Inc. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jun 26, 2023 | 1 | $0 | 4 | Jun 28, 2023 | Director |
| TIL | Instil Bio, Inc. | Jan 8, 2023 | 1 | $0 | 4 | Jan 20, 2023 | CFO and CBO |
| BTAI | BioXcel Therapeutics, Inc. | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
| TIL | Instil Bio, Inc. | Mar 4, 2022 | 1 | $0 | 4/A | Jan 20, 2023 | CFO and CBO |
| HILS | Hillstream BioPharma Inc. | Jan 11, 2022 | 0 | $0 | 3 | Jan 11, 2022 | 10%+ Owner |
| UNCY | Unicycive Therapeutics, Inc. | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |
| TIL | Instil Bio, Inc. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | CFO and CBO |